Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Operating Expenses | 43,002 | 0 | 0 | 0 |
| Operating Income | -43,002 | N/A | N/A | N/A |
| Interest Expense | 28 | 0 | 0 | 0 |
| Other Income | -16,981 | 0 | 0 | 0 |
| Pre-tax Income | -60,011 | 0 | 0 | 0 |
| Net Income Continuous | -60,011 | N/A | N/A | N/A |
| Net Income | $-60,011 | $0 | $N/A | $N/A |
| EPS Basic Total Ops | -3.40 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -3.40 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.40 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -3.40 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -3.40 | N/A | N/A | N/A |
| EBITDA(a) | $-42,993 | $N/A | $N/A | $N/A |